Growing community of inventors

Nijmegen, Netherlands

Peter Johannes Goedings

Average Co-Inventor Count = 2.86

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 41

Peter Johannes GoedingsPatrick Henry Beusker (3 patents)Peter Johannes GoedingsGijsbertus Franciscus Maria Verheijden (3 patents)Peter Johannes GoedingsWillem Dokter (3 patents)Peter Johannes GoedingsAlessandro D Santin (2 patents)Peter Johannes GoedingsAlessandro Davide Santin (1 patent)Peter Johannes GoedingsGijsbertus Franciscus Maria Verheijden (1 patent)Peter Johannes GoedingsAlessandro Davide Santin (0 patent)Peter Johannes GoedingsPeter Johannes Goedings (5 patents)Patrick Henry BeuskerPatrick Henry Beusker (14 patents)Gijsbertus Franciscus Maria VerheijdenGijsbertus Franciscus Maria Verheijden (6 patents)Willem DokterWillem Dokter (3 patents)Alessandro D SantinAlessandro D Santin (19 patents)Alessandro Davide SantinAlessandro Davide Santin (2 patents)Gijsbertus Franciscus Maria VerheijdenGijsbertus Franciscus Maria Verheijden (1 patent)Alessandro Davide SantinAlessandro Davide Santin (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Synthon Biopharmaceuticals B.v. (4 from 11 patents)

2. Yale University (2 from 1,327 patents)

3. Byondis B.v. (1 from 18 patents)


5 patents:

1. 11382982 - Duocarmycin ADCs showing improved in vivo antitumor activity

2. 10603387 - Duocarmycin ADCs showing improved in vivo antitumor activity

3. 10092659 - Duocarmycin ADCs for use in treatment of endometrial cancer

4. 9427480 - Duocarmycin ADCs for use in treatment of endometrial cancer

5. 9421278 - Duocarmycin ADCS showing improved in vivo antitumor activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…